Goodbye, ALOHA!

Goodbye suxamethonium!

No drugs in anaesthesia are more problematic than suxamethonium. Yet, no drugs have survived as suxamethonium does in spite of crisis after crisis, and attempt after attempt at its replacement. For decades, suxamethonium has taught us neuromuscular pharmacology and provided us with an encyclopaedia of side effects, while benefiting millions and millions of our anaesthetised patients. With the a...

Goodbye to ABCD resuscitation?

Saying goodbye.

engineering of monoterpene biosynthesis in tomato fruits via introduction of the non‐canonical substrate neryl diphosphate. Metab. Eng. 24: 107‐116. Rescue of syringyl lignin and sinapate ester biosynthesis in Arabidopsis thaliana by a coniferaldehyde 5‐hydroxylase from Eucalyptus globulus. phosphoproteomics of activated B cells using complementary metal ion functionalized soluble nanopolymers....

Goodbye Decompression Sickness

by T.J.R. Francis, D.J. Smith and J.J. W. Sykes, Institute of Naval Medicine, Hampshire, England. The current means by which we classify decompression sickness dates back only 30 years to the experience gained during the construction of the Dartford Tunnel in London. Golding et al [1] proposed a system for decompression sickness based upon perceived severity of the cases which arose in the cais...

Thank you and goodbye.

This is the last issue under the present team’s Editorialship and we would like to thank our dedicated readership, authors, reviewers and the members of the Editorial Board sincerely for their support and encouragement. Over the last three years, we were able to steadily improve and strengthen POI’s scientific content leading to its wider recognition in the field of rehabilitation. This increas...